Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ganglioneuroblastoma × Irinotecan × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 27 Pancreatic Neoplasms 12 Neuroblastoma 10 Stomach Neoplasms 9 Neoplasm Metastasis 9 Neoplasms 7 Rectal Neoplasms 5 Small Cell Lung Carcinoma 3 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Ovarian Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colonic Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Sarcoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Biliary Tract Neoplasms 2 Advanced Solid Tumors 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Refractory Solid Tumors 1

Interventions

dinutuximab 2 sargramostim 1 lorlatinib 1 etoposide phosphate 1 Vincristine 1 Topotecan 1 Thiotepa 1 Temozolomide 1 Stem Cell Transplantation 1 Specimen Handling 1 Razoxane 1 Radiation 1 Proton Therapy 1 Platinum 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Isotretinoin 1 Irinotecan 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Congresses as Topic 1 Colony-Stimulating Factors 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Biopsy 1 3-Iodobenzylguanidine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡